Brief: Cel-Sci Presents Phase 3 Multikine Head And Neck Cancer Data

CEL-SCI

07/06/2022 12:38

June 7 (Reuters) - CEL-SCI Corp  CVM.A :
    * CEL-SCI PRESENTS PHASE 3 MULTIKINE HEAD & NECK CANCER DATA
AT
ASCO
    * CEL-SCI CORP- INTENDS TO FILE A BIOLOGIC LICENSE
APPLICATION
WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR APPROVAL OF
THIS INDICATION

Source text for Eikon:  ID:nBw1lcZ37a 
Further company coverage:  CVM.A 

 ((reuters.briefs@thomsonreuters.com;))